TY - JOUR AU - Roddam, A. W. AU - Duffy, M. J. AU - Hamdy, F. C. PY - 2005 DA - 2005// TI - Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis JO - Eur Urol VL - 48 UR - https://doi.org/10.1016/j.eururo.2005.04.015 DO - 10.1016/j.eururo.2005.04.015 ID - Roddam2005 ER - TY - JOUR AU - Catalona, W. J. AU - Hudson, M. A. AU - Scardino, P. T. PY - 1994 DA - 1994// TI - Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves JO - J Urol VL - 152 ID - Catalona1994 ER - TY - JOUR AU - Kok, J. B. AU - Verhaegh, G. W. AU - Roelofs, R. W. PY - 2002 DA - 2002// TI - DD3(PCA3), a very sensitive and specific marker to detect prostate tumors JO - Cancer Res VL - 62 ID - Kok2002 ER - TY - JOUR AU - Gils, M. P. M. Q. AU - Hessels, D. AU - Hooij, O. PY - 2007 DA - 2007// TI - The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2679 DO - 10.1158/1078-0432.CCR-06-2679 ID - Gils2007 ER - TY - JOUR AU - Hessels, D. AU - Schalken, J. A. PY - 2009 DA - 2009// TI - The use of PCA3 in the diagnosis of prostate cancer JO - Nat Rev Urol VL - 6 UR - https://doi.org/10.1038/nrurol.2009.40 DO - 10.1038/nrurol.2009.40 ID - Hessels2009 ER - TY - JOUR AU - Ploussard, G. AU - Durand, X. AU - Xylinas, E. PY - 2011 DA - 2011// TI - Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2010.11.044 DO - 10.1016/j.eururo.2010.11.044 ID - Ploussard2011 ER - TY - JOUR AU - Sciarra, A. AU - Panebianco, V. AU - Cattarino, S. PY - 2012 DA - 2012// TI - Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy JO - BJU Int VL - 110 UR - https://doi.org/10.1111/j.1464-410X.2012.11146.x DO - 10.1111/j.1464-410X.2012.11146.x ID - Sciarra2012 ER - TY - JOUR AU - Leyten, G. H. J. M. AU - Wierenga, E. A. AU - Sedelaar, J. P. M. PY - 2013 DA - 2013// TI - Value of PCA3 to predict biopsy outcome and its potential role in selecting patients for multiparametric MRI JO - Int J Mol Sci VL - 14 UR - https://doi.org/10.3390/ijms140611347 DO - 10.3390/ijms140611347 ID - Leyten2013 ER - TY - JOUR AU - Panebianco, V. AU - Sciarra, A. AU - Berardinis, E. PY - 2011 DA - 2011// TI - PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations JO - Anticancer Res VL - 31 ID - Panebianco2011 ER - TY - STD TI - Prostate cancer: diagnosis and management. NICE, January 2014. Available via http://www.nice.org.uk/guidance/CG175. Accessed 16 Oct 2016. UR - http://www.nice.org.uk/guidance/CG175 ID - ref10 ER - TY - JOUR AU - Sato, C. AU - Naganawa, S. AU - Nakamura, T. PY - 2005 DA - 2005// TI - Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate JO - J Magn Reson Imaging VL - 21 UR - https://doi.org/10.1002/jmri.20251 DO - 10.1002/jmri.20251 ID - Sato2005 ER - TY - JOUR AU - Lim, H. K. AU - Kim, J. K. AU - Kim, K. A. AU - Cho, K. PY - 2009 DA - 2009// TI - Prostate cancer : apparent diffusion coefficient map with T2-weighted images for detection — a multireader purpose : methods : results : conclusion JO - Radiology VL - 250 UR - https://doi.org/10.1148/radiol.2501080207 DO - 10.1148/radiol.2501080207 ID - Lim2009 ER - TY - JOUR AU - Gibbs, P. AU - Liney, G. P. AU - Pickles, M. D. PY - 2009 DA - 2009// TI - Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla JO - Invest Radiol VL - 44 UR - https://doi.org/10.1097/RLI.0b013e3181b4c10e DO - 10.1097/RLI.0b013e3181b4c10e ID - Gibbs2009 ER - TY - JOUR AU - Riches, S. F. AU - Hawtin, K. AU - Charles-Edwards, E. M. AU - Souza, N. M. PY - 2009 DA - 2009// TI - Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients JO - NMR Biomed VL - 22 UR - https://doi.org/10.1002/nbm.1328 DO - 10.1002/nbm.1328 ID - Riches2009 ER - TY - JOUR AU - Panagiotaki, E. AU - Walker-Samuel, S. AU - Siow, B. PY - 2014 DA - 2014// TI - Noninvasive quantification of solid tumor microstructure using VERDICT MRI JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-2511 DO - 10.1158/0008-5472.CAN-13-2511 ID - Panagiotaki2014 ER - TY - STD TI - Panagiotaki E, Chan RW, Dikaios N, et al. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging. Invest Radiol. 2015;00:1–10. ID - ref16 ER - TY - JOUR AU - Alexander, D. C. PY - 2008 DA - 2008// TI - A general framework for experiment design in diffusion MRI and its application in measuring direct tissue-microstructure features JO - Magn Reson Med VL - 60 UR - https://doi.org/10.1002/mrm.21646 DO - 10.1002/mrm.21646 ID - Alexander2008 ER - TY - JOUR AU - Ahmed, H. U. AU - Hu, Y. AU - Carter, T. PY - 2011 DA - 2011// TI - Characterizing clinically significant prostate cancer using template prostate mapping biopsy JO - J Urol VL - 186 UR - https://doi.org/10.1016/j.juro.2011.03.147 DO - 10.1016/j.juro.2011.03.147 ID - Ahmed2011 ER - TY - JOUR AU - Kirkham a, P. S. AU - Haslam, P. AU - Keanie, J. Y. PY - 2013 DA - 2013// TI - Prostate MRI: who, when, and how? Report from a UK consensus meeting JO - Clin Radiol VL - 68 UR - https://doi.org/10.1016/j.crad.2013.03.030 DO - 10.1016/j.crad.2013.03.030 ID - Kirkham a2013 ER - TY - JOUR AU - Barentsz, J. O. AU - Richenberg, J. AU - Clements, R. PY - 2012 DA - 2012// TI - ESUR prostate MR guidelines 2012 JO - Eur Radiol VL - 22 UR - https://doi.org/10.1007/s00330-011-2377-y DO - 10.1007/s00330-011-2377-y ID - Barentsz2012 ER - TY - JOUR AU - Dickinson, L. AU - Ahmed, H. U. AU - Allen, C. PY - 2011 DA - 2011// TI - Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting JO - Eur Urol VL - 59 UR - https://doi.org/10.1016/j.eururo.2010.12.009 DO - 10.1016/j.eururo.2010.12.009 ID - Dickinson2011 ER - TY - JOUR AU - Arumainayagam, N. AU - Ahmed, H. U. AU - Moore, C. M. PY - 2013 DA - 2013// TI - Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard JO - Radiology VL - 268 UR - https://doi.org/10.1148/radiol.13120641 DO - 10.1148/radiol.13120641 ID - Arumainayagam2013 ER - TY - JOUR AU - Padhani, A. R. AU - Liu, G. AU - Koh, D. M. PY - 2009 DA - 2009// TI - Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations JO - Neoplasia VL - 11 UR - https://doi.org/10.1593/neo.81328 DO - 10.1593/neo.81328 ID - Padhani2009 ER - TY - JOUR AU - Lioumi, M. AU - Newell, D. PY - 2010 DA - 2010// TI - CR-UK biomarker roadmaps JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/DIAG-10-B33 DO - 10.1158/DIAG-10-B33 ID - Lioumi2010 ER - TY - JOUR AU - Ukimura, O. AU - Coleman, J. A. AU - Taille, A. PY - 2013 DA - 2013// TI - Contemporary role of systematic prostate biopsies: Indications, techniques, and implications for patient care JO - Eur Urol VL - 63 UR - https://doi.org/10.1016/j.eururo.2012.09.033 DO - 10.1016/j.eururo.2012.09.033 ID - Ukimura2013 ER - TY - JOUR AU - Lecornet, E. AU - Ahmed, H. U. AU - Hu, Y. PY - 2012 DA - 2012// TI - The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation JO - J Urol VL - 188 UR - https://doi.org/10.1016/j.juro.2012.04.104 DO - 10.1016/j.juro.2012.04.104 ID - Lecornet2012 ER - TY - JOUR AU - Djavan, B. AU - Ravery, V. AU - Zlotta, A. PY - 2001 DA - 2001// TI - Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? JO - J Urol VL - 166 UR - https://doi.org/10.1016/S0022-5347(05)65652-2 DO - 10.1016/S0022-5347(05)65652-2 ID - Djavan2001 ER - TY - JOUR AU - McNeal, J. E. AU - Redwine, E. A. AU - Freiha, F. S. AU - Stamey, T. A. PY - 1988 DA - 1988// TI - Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread JO - Am J Surg Pathol VL - 12 UR - https://doi.org/10.1097/00000478-198812000-00001 DO - 10.1097/00000478-198812000-00001 ID - McNeal1988 ER - TY - STD TI - CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02689271?term=prostate+INNOVATE&rank=1. UR - https://clinicaltrials.gov/ct2/show/NCT02689271?term=prostate+INNOVATE&rank=1 ID - ref29 ER -